Andrew Scharenberg, Umoja Biopharma CEO
Umoja’s $100M Series C will advance its bid for more convenient cell therapies
In the 10th megaround of 2025, Umoja Biopharma has banked $100 million in a Series C fundraise with an eye to advancing its pipeline of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
